جستجوی مقالات مرتبط با کلیدواژه « CNS diseases » در نشریات گروه « پزشکی »
-
Introduction
Central Nervous System (CNS) is one of the most important organs which is managing so many functions in human body. So, impairment of its function may results in several disorders in body, or CNS diseases, which are considered very important. CNS diseases are divided into many different groups and each group is treated with its own related medication. Some drugs that are used for treating CNS impairments have disadvantages like short length effect, renal and digestive toxicities and restrictions in pharmaceutical form. Some other drugs may cause complications worse than disease itself so the scientist shouls find the ways to solve these problems.
Methodsfirst “Scopus”, “PubMed”, and “ScienceDirect” were searched with the keywords “CNS”. “CNS diseases” and “lipid based nanoparticles” and the whole articles were collected; then the most irrelevant and inappropriate articles was removed and 105 articles were remained; at the last section of article selection the best articles was selected from the 105 articles that were remained and the finally selected articles were reviewed and this article was written.
ResultsThe review of many important articles and summarizing them was shown that the scientists and drug designers have used many ways to overcome all or some of the disadvantages of the CNS drug delivery (as mentioned above) and they found that one of the best ways to fix these bugs is using lipid-based nanoparticles in nanotechnology field.
Keywords: Central Nervous system (CNS), CNS diseases, infectious diseases, In vivo tests, In vitro tests, Lipid based nanoparticles, Tumor} -
Biolmpacts, Volume:6 Issue: 2, Jun 2016, PP 69 -70This is a brief report of the 19th Annual Meeting of the American Society of Gene and Cell Therapy that took place from May 4th through May 7th, 2016 in Washington, DC, USA. While the meeting provided many symposiums, lectures, and scientific sessions this report mainly focuses on one of the sessions on the Gene Therapy for central nervous system (CNS) Diseases and specifically on the Gene Therapy for the globoid cell leukodystrophy or Krabbe disease. Two presentations focused on this subject utilizing two animal models of this disease: mice and dog models. Different serotypes of adeno-associate viral vectors (AAV) alone or in combination with bone marrow transplantations were used in these research projects. The Meeting of the ASGCT reflected continuous growth in the fields of gene and cell therapy and brighter forecast for efficient treatment options for variety of human diseases.Keywords: CNS diseases, Gene therapy, Krabe disease}
- نتایج بر اساس تاریخ انتشار مرتب شدهاند.
- کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شدهاست. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
- در صورتی که میخواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.